No Data
No Data
Inventiva Gets New Funding for Late-stage Trial of Fatty Liver Disease Treatment
Inventiva Names New Chairman
Inventiva Announces the Availability of a Prospectus in Connection With Its Financing Through the Issuance of Ordinary Shares and Pre-funded Warrants
Inventiva Secures up to $380m for MASH Treatment Lanifibranor
Why Is Fatty-Liver Drug Developer Inventiva Stock Trading Higher On Monday?
Stifel Maintains Inventiva(IVA.US) With Buy Rating
No Data
No Data